Collagen ORC Sponge Encapsulated in Chitosan Envelope
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing wound dressings face challenges with biocompatibility, bioavailability, wound exudate absorption, extended efficacy, storage stability, ease of clinical use, and cost, necessitating improved materials and designs for enhanced wound healing.
Innovation Solution
The development of wound dressings comprising a bioresorbable sponge made of oxidized regenerated cellulose (ORC) and collagen, encapsulated within a polysaccharide polymer envelope, such as chitosan, which includes optional therapeutic agents and a perforated top sheet for controlled bioresorption and fluid permeability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a bioresorbable sponge comprising ORC and collagen is used as the absorbent structure, then biocompatibility and tissue regeneration are improved, but structural stability and durability are reduced
Solution Approach 1:
The absorbent structure combines oxidized regenerated cellulose (ORC) and collagen in a composite sponge formulation. ORC provides structural framework and absorbency, while collagen enhances biocompatibility and promotes tissue regeneration. This composite approach allows the dressing to maintain structural integrity during the healing process while gradually degrading as new tissue forms, resolving the contradiction between biocompatibility and structural stability.
2Ease of operation
If the absorbent structure is made fully bioresorbable, then ease of removal and patient comfort are improved, but control over degradation timing and rate is reduced
Solution Approach 1:
The degradation rate of the bioresorbable sponge is controlled by adjusting key parameters including the ratio of ORC to collagen, the degree of oxidation of the cellulose, and the porosity of the sponge structure. By optimizing these parameters, the dressing maintains adequate structural stability during the critical healing phase while ensuring complete resorption within a controlled time frame (typically 2-8 weeks), providing both ease of removal and degradation control.
3Productivity
If the top sheet is made fluid permeable with perforations, then wound exudate absorption and drainage are improved, but structural integrity and protection are reduced
Solution Approach 1:
The top sheet is designed with a porous structure containing controlled perforations and interconnected voids. This porous architecture allows wound exudate to pass through efficiently while the surrounding matrix material maintains structural integrity. The pore sizes and distribution are optimized to balance fluid drainage capabilities with mechanical strength, ensuring the dressing remains intact during handling and wear while effectively managing exudate.
4Reliability
If therapeutic agents are incorporated into the dressing layers, then wound healing efficacy is improved, but manufacturing complexity and cost are increased
Solution Approach 1:
Therapeutic agents such as antimicrobials, growth factors, or anti-inflammatory compounds are incorporated directly into the absorbent sponge matrix or top sheet material during the manufacturing process. This merging of therapeutic functionality with the structural components eliminates the need for separate application steps or additional layers, thereby enhancing healing efficacy while minimizing manufacturing complexity. The agents are uniformly distributed within the dressing structure, ensuring consistent therapeutic delivery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dressings provide effective wound healing by modulating proteases, absorbing exudate, and promoting tissue regeneration, with controlled degradation rates and extended usage intervals, reducing the need for frequent dressing changes and improving clinical usability.
Implementation Method 1
an absorbent structure, preferably a bioresorbable sponge
Implementation Method 2
The top sheet may be fluid permeable; for example, comprising a plurality of perforations
Implementation Method 3
controlled bioresorption and fluid permeability
Implementation Method 4
encapsulated within a polysaccharide polymer envelope, such as chitosan, which includes optional therapeutic agents and a perforated top sheet for controlled bioresorption
Implementation Method 5
controlled degradation rates and extended usage intervals
Data Source
AI summary
Wound dressing compositions comprising of a bioresorbable sponge encapsulated within a polysaccharide envelope. The bioresorbable sponge is preferably comprised of collagen and oxidised regenerated cellulose. The outer polysaccharide envelope is preferably comprised of chitosan. The outer polysaccharide envelope functions to modulate the rate at which the bioresorbable sponge breaks down within a wound.